The cells with electrophysiological activity obtained at the University of the Basque Country (UPV/EHU) are opening up new avenues for the study of neurodegenerative diseases and the development of ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

There is very little known about LGS. Of patients who have been diagnosed withit, 30-35% do not have a known cause.

Cells with electrophysiological activity obtained at the University of the Basque Country (UPV/EHU) are opening up new ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

The effect of levetiracetam on high-frequency oscillations in patients with AD and epilepsy shows its potential as a biomarker for disease detection.

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

Sea’s pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system) ...

Gyratory seizures are rare neurological episodes causing involuntary, forceful body rotation, often linked to frontal lobe ...

Scientists used advanced cryo-EM imaging to reveal how glutamate activates brain receptors, paving the way for new ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

2024 — A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with ...